---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-000772"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2026-02-12T23:59:59+00:00"
generated_at: "2026-05-16T03:02:19.652863+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Profound Medical receives Mount Logan Award; touts 4,000th TULSA case, new US codes, direct sales expansion

## Summary
- INOVAIT honored Profound with the 2025-2026 Mount Logan Award for TULSA Procedure commercialization.
- Company treated 4,000th TULSA patient and secured new Medicare reimbursement codes in the US.
- Regained exclusive Canadian distribution rights; deploying direct sales team in North America.
- Sunnybrook Health Sciences Centre performed over 100 TULSA procedures despite no provincial insurance coverage.

## SEC filing metadata
- accession: 0001171843-26-000772
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2026-02-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000117184326000772/0001171843-26-000772-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000117184326000772/f8k_021226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-000772
- JSON: https://secwatch.observer/filing/0001171843-26-000772.json
- Plain text: https://secwatch.observer/filing/0001171843-26-000772.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.